Measure the activity of the sympathetic, the parasympathetic nervous system with every heartbeat and the balance trajectory between them. Use the ANSiscope to monitor Chronic pain

Home
The Company
Products
Technology
Applications
Faq
Newsletters
Posters & Presentations
Publications
Press Coverage
Info for Doctors
Info for Patients
Info for Researchers
Info for Distribution Partners
Info for OEMs
Info for Investors
Links
Contact Us
ANS Forum










Since the 1930s, it has been known that the variability of RR Intervals is the only known indicator of the activity of the ANS..
The ANSiscope offers invaluable help for patients in the areas of

  Diabetes (need for early detection and assessment of Diabetic Autonomic Neuropathy),
  Anesthesiology (need to be patient-specific and find safer procedures to dose drugs while anaesthetizing a patient).
  Cardiology (need to risk stratify patients).
  Measurement of autonomic dysfunction (need to measure the operation of the autonomic nervous system).

The ANSiscope is the only product to measure sympathetic and parasympathetic systems in real time and display both simultaneously

Previous methods to analyze variations of RR-intervals could only qualify, for example, one activity in increase or decrease of RR-intervals. The methods used are :

Statistical indices (time domain)
Spectral analysis (frequency domain)
Chaos theory invariants : correlation dimension, Lyapunov exponents.

The ANSiscope will be useful in future applications
In the areas of neonatal monitoring.
Sleep apnea
many other applications where the ANS is critical, e.g. cases of autonomic dysfunction (such as Parkinson's disease)
   
   
News and Events
American Diabetes Association Recommends screening for Autonomic Neuropathy
 
Screening for autonomic neuropathy should be instituted at diagnosis of type 2 diabetes and 5 years after the diagnosis of type 1 diabetes
 
American Diabetes Association (ADA), Standard of Medical care in Diabetes, 2006
 
Dyansys introduces Portable ECScope for general physicians/ primary care providers
 
Dyansys gains ISO 13485:2003 certification for Portable ANSiscope, Portable ECScope
 

Dyansys is pleased to announces that European office has granted patent on ANSiscope technology for Germany, France & UK countries. Patent Number - 163947

 
Portable ANSiscope approved for FDA Certification
 
Portable ECScope approved for FDA Certification
Dyansys Product Family
The Portable ANSiscope and Portable ECScope for family physicians and field applications 
  more  
Dyansys Application
Chronic & Acute Pain
Anesthesiology
Cardiology
Diabetes
Fetal Heart Monitoring
Measurement of autonomic dysfunction
  more  
Copyright © 2009 DyAnsys Inc. All Rights Reserved
Site designed by Uditi Technologies